Abstract Hub Day 3 - Advances in screening and early detection

Abstract hub

Chaired by Ophira Ginsburg (New York University, US)


1. Mel Davis (BreastScreen Australia)

It is hard to reach migrant population in Victoria Australia mostly due to systemic barriers e.g. language, invitation for breast screening is only for electoral. Cross partnership can increase breast screening participation in migrant women in Victoria.

2. Jean-Marie Dusengimana (Harvard Medical School)

Rwanda breast cancer early detection project: closing the intervals in the symptom-treatment period.1076 community health workers, 127 nurses at health centres and 9 hospital nurses and doctors are trained, resulted in more cancer early detection at the health care centres. 

3. Je-Yu Lin (National Taiwan University): 

Information system of national population based cervical-screening can be supported by using real time big data for visualization ad decision-making analysis.

4. Beatrice Lauby-Secretan  (IARC WHO) 

Latest IARC recommendation for colorectal cancer (CRC) screening (covered in IARC Handbook Vol 17).  

Sufficient evidence that screening with (1) Guaiac Fecal Occult Blood (gFOBT) (without rehydration and gFOBT with higher sensitivity), (2) sigmoidescopy  (3) colonoscopy, and Fecal Immunochemical Test (FIT) reduce CRC mortality and has recommended benefit-harm ratio. Screening with sigmoidoscopy and colonoscopy also reduce CRC incidence. 

Single screening with CTC (Computer Tomographic Colonography) has limited  evidence that it reduces CRC incidence and mortality.

5. Chen Sam Li-Cheng (National Taiwan University)

Fecal hemoglobin (f-Hb) is found to be linked with oral potentially malignant disorders (OPMD) f-Hb. From this finding, we suggest personalised screening for oral cancer early detection. 

6. Sok Cheong (Cancer Research Malaysia)

Despite the very simple screening method, late detection is common in oral cancer patients. We developed Mobile Mouth Screening Anywhere (MeMoSA) to improve early detection, connecting dentists and specialists.

7. Robert Smith (American Cancer Society) 

We measured incidence rate of fatal breast cancer within 10 and 20 years using registries of Dalarna, Sweden.

Women who chose to participate in the organised breast cancer screening programme had a 60% lower risk of dying from breast cancer within 10 years after diagnosis, and a 47% lower risk of dying from breast cancer within 20 years after diagnosis, compared to the corresponding risks for the non-participants.